Real-World Efficacy and Safety of First-Line Nivolumab Plus Chemotherapy in Patients with Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Nationwide Observational Turkish Oncology Group (TOG) Study.

Autor: Kutlu, Yasin1 (AUTHOR) dryasinkutlu@gmail.com, Dae, Shute Ailia2 (AUTHOR), Yilmaz, Feride3 (AUTHOR), Erdem, Dilek4 (AUTHOR), Sendur, Mehmet Ali Nahit5 (AUTHOR), Akbas, Sinem6 (AUTHOR), Senocak Tasci, Elif7 (AUTHOR), Bas, Onur3 (AUTHOR), Dane, Faysal8 (AUTHOR), Sakin, Abdullah9 (AUTHOR), Kaya, Ali Osman10 (AUTHOR), Aykan, Musa Baris11 (AUTHOR), Ergun, Yakup12 (AUTHOR), Biter, Sedat13 (AUTHOR), Disel, Umut14 (AUTHOR), Korkmaz, Mustafa15 (AUTHOR), Selcukbiricik, Fatih6 (AUTHOR), Kose, Fatih2 (AUTHOR), Olmez, Omer Fatih1 (AUTHOR), Bilici, Ahmet1 (AUTHOR)
Zdroj: Cancers. Jun2024, Vol. 16 Issue 12, p2251. 12p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje